Stockreport

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF The overall position value increased by $57.25 million from the previous period. As of September 30, Suvretta reported holding 2.13 million MLYS shares valued at $80. [Read more]